Skip to main navigation Skip to search Skip to main content

Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

  • Nicholas Andrikopoulos
  • , Yuhuan Li
  • , Luca Cecchetto
  • , Aparna Nandakumar
  • , Tatiana Da Ros
  • , Thomas P. Davis
  • , Kelly Velonia
  • , Pu Chun Ke

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Amyloid diseases are global epidemics with no cure currently available. In the past decade, the use of engineered nanomaterials as inhibitors or probes against the pathogenic aggregation of amyloid peptides and proteins has emerged as a new frontier in nanomedicine. In this Minireview, we summarize for the first time the pivotal role of chemical synthesis in enabling the development of this multidisciplinary field.

Original languageEnglish
Pages (from-to)14422-14440
Number of pages19
JournalNanoscale
Volume12
Issue number27
DOIs
Publication statusPublished - 16 Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this